Trial intelligence / Profile preview

Cisplatin/Vinblastine vs Paclitaxel/Carboplatin in Locally Advanced NSCLC

NCT03092986Phase 4Completed

Sponsor
Bangabandhu Sheikh Mujib Medical University
Start
Jan 2017
Primary completion
Jun 2018
Modality
Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Cisplatin micelle injection (HA132), vinblastine in non-small cell lung cancer (NSCLC), sponsored by Bangabandhu Sheikh Mujib Medical University. Started Jan 2017; status: completed.

02

Drugs

Cisplatin micelle injection (HA132)vinblastine
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT03092986.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03092986.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call